Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment Randomized Controlled Parallel Group Study
Özet
Current guidelines recommend the use of low molecular weight heparin (LMWH) for most haemodynamically stable patients with pulmonary thromboembolism (PTE), however, it is not clear whether LMWH is preferable to unfractionated heparin (UFH) for the treatment of massive PTE. We aimed to compare the use of LMWH versus UFH after thrombolytic treatment in the management of acute massive PTE for hemorrhage and hospital mortality.
Anahtar kelimeler
Atıf için künye
Ucar, E. Y., Akgün, M., Araz, Ö., Tas, H., Kerget, B., Meral, M., Kaynar, H., & Sağlam, L. (2015). Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment Randomized Controlled Parallel Group Study. LUNG, 193(1), 121–127. https://doi.org/10.1007/s00408-014-9660-z
BibTeX
@article{ucar2015-226908,
author = {Ucar, Elif Yilmazel and Akgün, Metin and Araz, Ömer and Tas, Hakan and Kerget, Buğra and Meral, Mehmet and Kaynar, Hasan and Sağlam, Leyla},
title = {Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment Randomized Controlled Parallel Group Study},
journal = {LUNG},
year = {2015},
volume = {193},
number = {1},
pages = {121--127},
issn = {0341-2040},
doi = {10.1007/s00408-014-9660-z},
url = {https://akademik.atauni.edu.tr/yayinlar/226908-comparison-of-lmwh-versus-ufh-for-hemorrhage-and-hospital-mortality-in-the}
}